Discover 514 paid clinical trials in Madison, Wisconsin. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 514
A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder
for
Muscle-invasive Bladder Cancer
Location: Madison WI, Lisle IL, Chicago IL, Indianapolis IN,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT07475806
Phase2, Recruiting
Implementing AI-Assisted, Patient-Friendly Imaging Report Summaries to Enhance Oncology Care Delivery
for
Oncology
Location: Madison WI
Sponsor: University of Wisconsin, Madison
Sex: All
Age: 18+
Code: NCT07532083
Recruiting
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
Location: Madison WI, Milwaukee WI, Iowa City IA, Columbus OH,
Sponsor: SCRI Development Innovations, LLC
Sex: All
Age: 19+
Code: NCT06974786
Phase2, Recruiting
Video-based Patient Education Intervention for Diabetic Eye Screening in Latinx Communities
for
Diabetic Retinopathy
Location: Madison WI
Sponsor: University of Wisconsin, Madison
Sex: All
Age: 18+
Code: NCT06257082
Recruiting
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation
for
Multiple Myeloma
Location: Madison WI, Milwaukee WI, Green Bay WI, Chicago IL,
Sponsor: European Myeloma Network B.V.
Sex: All
Age: 18+
Code: NCT05243797
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A First-in-Human (FIH) Study of BG-C137, an Anti-Fibroblast Growth Factor Receptor 2b (FGFR2b) Antibody Drug Conjugate, in Participants With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Madison WI, New Haven CT, Houston TX, Seattle WA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06625593
Phase1, Recruiting
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
for
Carcinoma, Non-Small-Cell Lung
Location: Madison WI, Milwaukee WI, North Chicago IL, Chicago IL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06890598
Phase3, Recruiting
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
for
Idiopathic Pulmonary Fibrosis
Location: Madison WI, Chicago IL, Indianapolis IN, Royal Oak MI,
Sponsor: Cumberland Pharmaceuticals
Sex: All
Age: 40+
Code: NCT05571059
Phase2, Recruiting
A Study of ASP3082 in Adults With Advanced Solid Tumors
for
Solid Tumor
Location: Madison WI, Ypsilanti MI, St Louis MO, Maumee OH,
Sponsor: Astellas Pharma Inc
Sex: All
Age: 18+
Code: NCT05382559
Phase1, Recruiting
Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation
for
Infusion Reactions
Location: Madison WI, Milwaukee WI, Chicago IL, Grand Rapids MI,
Sponsor: New York Blood Center
Sex: All
Age: 0+
Code: NCT01656603
Phase2, Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
for
Pediatric Migraine
Location: Madison WI, Kenosha WI, Naperville IL, Chicago IL,
Sponsor: Pfizer
Sex: All
Age: 6 - 17
Code: NCT04649242
Phase3, Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
for
Acute Treatment of Migraine
Location: Madison WI, Naperville IL, Chicago IL, Grand Rapids MI,
Sponsor: Pfizer
Sex: All
Age: 6 - 17
Code: NCT04743141
Phase3, Recruiting
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)